Search by Drug Name or NDC

NDC 55150-0334-01 CARBOPLATIN 150 mg/15mL Details

CARBOPLATIN 150 mg/15mL

CARBOPLATIN is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is CARBOPLATIN.

MedlinePlus Drug Summary

Carboplatin is used alone or in combination with other medications to treat cancer of the ovaries (cancer that begins in the female reproductive organs where eggs are formed) that has spread to other parts of the body, not improved, or that has worsened after treatment with other medications or radiation therapy. Carboplatin is in a class of medications known as platinum-containing compounds. It works by stopping or slowing the growth of cancer cells.

Related Packages: 55150-0334-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Carboplatin Injection

Product Information

NDC	55150-0334
Product ID	55150-334_cfbace29-2dee-41d7-9025-8cc963adbc79
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	CARBOPLATIN
Proprietary Name Suffix	n/a
Non-Proprietary Name	CARBOPLATIN
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	150
Active Ingredient Units	mg/15mL
Substance Name	CARBOPLATIN
Labeler Name	Eugia US LLC
Pharmaceutical Class	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA205487
Listing Certified Through	2024-12-31

Package

NDC 55150-0334-01 (55150033401)

Pricing Information	N/A
NDC Package Code	55150-334-01
Billing NDC	55150033401
Package	1 VIAL, MULTI-DOSE in 1 CARTON (55150-334-01) / 15 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2016-09-29
NDC Exclude Flag	N